. 2011 May 20;14(5):446–451. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2011.05.12

1.

7例PEMZL- MALT患者临床资料

Clinical characteristics of the seven patients of PEMZL- MALT

Case	Gender	Age (year)	Symptoms	Past medical history and personal history	Chest CT findings		Primary diagnosis	Invasive examination methods	Duration of disease /months	Delay for diagnosis /months	Treatment	Status
		Age (year)		Past medical history and personal history	Location	Characteristics	Primary diagnosis	Invasive examination methods	Duration of disease /months	Delay for diagnosis /months
COP: cyclophosphamide, vincristine and prednisolone; R-COP: rituximab added to COP; CHOP: cyclophosphamide, doxorubicin, vincristine and prednisolone.
1	Female	37	Cough Sputum Chest pain Fever	None	Right upper lobe; Right middle lobe	Consolidation with air bronchogram	Pneumonia	Fiberoptic bronchoscopy	26	9	COP	Survival
2	Male	39	Cough Sputum Chest pain Fever	None	Right middle lobe; Both lower lobes	Consolidation	Pneumonia	Fiberoptic bronchoscopy (Four times)	35	24	R-COP	Survival
3	Female	54	Cough Sputum Fever	None	Right middle lobe	Consolidation with air bronchogram	Pneumonia, Tuberculosis	Fiberoptic bronchoscopy	6	1	None	Survival
4	Female	62	Cough Sputum Dyspnea Chest pain	Diabetes mellitus	Left upper lobe	Mass (5.1 cm×5.8 cm)	Lung cancer	Percutaneous pulmonary biopsy	18	0.75	CTX	Survival
5	Male	65	Cough Sputum Dyspnea	Smoking (10 pack^* Years)	Right upper lobe	Consolidation with left pleural effusion	Pneumonia, Tuberculosis	Fiberoptic bronchoscopy	3	1.5	CHOP	Survival
6	Female	67	None	Basal cell carcinoma	Right upper lobe; Right middle lobe	Consolidation with air bronchogram	Pneumonia	Fiberoptic bronchoscopy	23	0	COP	Survival
7	Female	74	Cough Sputum Dyspnea Fever	COPD	Right middle lobe	Consolidation	Pneumonia	Fiberoptic bronchoscopy	15	3	None	Died